GTR 102212833
Bids Are Invited For Dismissal With Dispute
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
102212833
Tendering Authority
Subscribe to view
Tender No
134/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Dismissal With Dispute
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
25-09-2025
Closed
Work Detail
Azithromycin Dosage: 40, Presentation: Oral Suspension, Betamethasone Composition: Dipropionate, Presentation: Associated With Ketoconazole, Dosage: 0, 5Mg + 20Mg/G, Use: Cream, Sulfametoxazole Composition: Associated With Trimetoprima, Concentration: 40Mg + 8Mg/Ml, Pharmaceutical Form: Oral Suspension, Ascorbic Acid Dosage Acid 100, Use Type: Injectable, Tranexamic Acid Dosage: 50, Pharmaceutical Form: Injectable Solution, 19/09/2025, Aminophylline Dosage: 24, Amoxicillin Active Principle: Associated With Potassium Clavulanate, Concentration: 50 Mg/Ml + 12, 5, Benzoilmetrinidazole Concentration: 40, Associated With Betamethathone Phosphate, Dosage 5Mg + 2Mg, Use: Injectable, Sodium Chloride Concentration: 0, 9 %, Pharmaceutical Form: Injectable Solution, Additional Characteristic: Closed System, Additional Characteristics 1: Pvc -Exempt Bag/Vial, Sodium Ceptriaxone Concentration: 500, Pharmaceutical Form: Powder For Injectable Solution, Ketoprofen Dosage: 20, Concentration: Oral Solution, Oral Solution, Colagenase Presentation: Associated With Chloramphenicol, Concentration: 0, 6Ui + 1%, Use: Ointment, Diazepam Dosage: 5, Presentation: Injectable Solution, Presentation: Associated With Sulfate Gentamicin, 5Mg + 1Mg/G, Epinephrine Dosage: 1Mg/Ml, Use: Injectable Solution With 100 1Ml Ampoules Each, Scopolamine Butylbromide, Dosage: 20, Indication: Injectable Solution With 100 1Ml Ampoules Each, Furosemide Composition: 10 Mg/Ml, Presentation: Injectable Solution With 5 2Ml Ampoules Each, Absorbable Hemostatic Presentation: Sponge, Active Ingredient: Collagen Microfibrillary, Dimensions: About 10 X 10, Sterility*: Disposable And Sterile Box With 10 Units, Type: Human, Type: Human Type: Human Nph, Dosage: 100U/Ml, Application: Injectable, Lidocaine Hydrochloride Dosage: 2%, Presentation: Injectable, Lidocaine Hydrochloride Dosage: 5%, Presentation: Ointment, Midazolam Dosage: 5, Meropenem Dosage: 500 Mg, Presentation: Injectable Boxes With 10 Flasks Ampoule, Mucopolsacchaement: Composition: Poissulfate, Concentration: 3, Pharmaceutical Form: Gel, Neomicin Composition: Associated With Bacitracin, Concentration: 5Mg + 250Ui/ G, Type Of Medication: Nitazoxanide Concentration: 20, Pharmaceutical Form: Powder For Oral Suspension, Sodium Picosulfate Presentation: Associated With Light Mineral Oil + Agar Agar, 334Mg + 282, 25Mg + 2, 72Mg/Ml, Indication: Oral, With Flavor, Probiotic Composition: Bacillus Cereus, Concentration: 5 Million Endospores/Ml, Pharmaceutical Form: Oral Suspension Boxes With 10 5Ml Flacontes Each, Probiotic Composition: Saccharomyces Boulardii - 17, Concentration: 200 Box With 4 Envelopes, Propofol Dosage: 10, Form Pharmaceutical: Injectable Emulsion, Rifamycin Dosage: 10, Indication: Spray, Secnidazole Concentration: 30, Use: Oral Suspension, Simeticona Concentration: 75, Pharmaceutical Form: Oral Emulsion - Drops, Sulfacetamide Composition: Associated With Trietanolamine, Dosage: 74 Mg + 21, 67 Mg/G Tramadol Hydrochloride Dosage: 50, Pharmaceutical Form: Slow Release, B Vitamins B Basic Composition: B1 + B6 + B12, Use: Injectable Solution, Diclofenac Presentation: Sodium Salt, Dosage: 1Mg/Ml, Use: Ophthalmic Solution, Albendazole Dosage: 40, Triacinolone Composition, Concentration*: 1, Form Pharmaceutical*: Oral Paste, Ringer Composition: Associated With Sodium Lactate, Additional Characteristic: Closed System, Glucose Concentration: 50%, Indication: Injectable Solution, Prednisolone Composition: Sodium Phosphate, For
Key Value
Tender Value
12,441 - BRL
Tender Documents
Global Tender Document
209b3e9e-17f6-4478-98c6-a58108d9f30c.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.